Prof. Dr. Werner Hohenberger



Organisationseinheit


Chirurgische Klinik
Lehrstuhl für Allgemein- und Viszeralchirurgie


Preise / Auszeichnungen


2002 : Mitgliedschaft Nationale Akademie der Wissenschaften Leopoldina


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 8 Go to next page Go to last page

Merkel, S., Weber, K., Brunner, M., Baecker, J., Agaimy, A., Göhl, J.,... Grützmann, R. (2019). Prognostic subdivision of pT2 rectal carcinomas. International Journal of Colorectal Disease, 34(3), 409-415. https://dx.doi.org/10.1007/s00384-018-3216-2
Kitz, J., Fokas, E., Beissbarth, T., Stroebel, P., Wittekind, C., Hartmann, A.,... Hohenberger, W. (2018). Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Surgery, 153(8). https://dx.doi.org/10.1001/jamasurg.2018.1607
Von Den Gruen, J.M., Hartmann, A., Fietkau, R., Ghadimi, M., Liersch, T., Hohenberger, W.,... Fokas, E. (2018). Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. Radiotherapy and Oncology, 128(3), 557-563. https://dx.doi.org/10.1016/j.radonc.2018.06.008
Hofheinz, R.-D., Arnold, D., Fokas, E., Kaufmann, M., Hothorn, T., Folprecht, G.,... Graeven, U. (2018). Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial. Annals of Oncology, 29(8), 1793-1799. https://dx.doi.org/10.1093/annonc/mdy205
Sprenger, T., Beissbarth, T., Sauer, R., Tschmelitsch, J., Fietkau, R., Liersch, T.,... Ghadimi, M. (2018). Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94. British Journal of Surgery, 105(11), 1510-1518. https://dx.doi.org/10.1002/bjs.10877
Fokas, E., Fietkau, R., Hartmann, A., Hohenberger, W., Grützmann, R., Ghadimi, M.,... Roedel, C. (2018). NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial. (pp. S142-S142).
Fokas, E., Fietkau, R., Hartmann, A., Hohenberger, W., Grützmann, R., Ghadimi, M.,... Roedel, C. (2018). Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Annals of Oncology, 29(7), 1521-1527. https://dx.doi.org/10.1093/annonc/mdy143
Wittel, U.A., Golcher, H., Gruetzmann, R., Bechstein, W.O., Belyaev, O., Uhl, W.,... Fietkau, R. (2018). Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21). (pp. 169-170).
Merkel, S., Schellerer, V., Wein, A., Semrau, S., Geppert, C., Göhl, J.,... Grützmann, R. (2018). The influence of tumour site on prognosis in metastatic colorectal carcinomas with primary tumour resection. International Journal of Colorectal Disease, 33(9), 1215-1223. https://dx.doi.org/10.1007/s00384-018-3098-3
Nolte, S., Zlobec, I., Lugli, A., Hohenberger, W., Croner, R., Merkel, S.,... Rau, T. (2017). Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients. Journal of Pathology: Clinical Research, 3(1), 58-70. https://dx.doi.org/10.1002/cjp2.62

Zuletzt aktualisiert 2017-16-10 um 02:00